Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Averica Discovery Systems
Averica Discovery Systems
Activities:
Research & Development
X
LinkedIn
Trending Articles
Counteracting counterfeits in the pharmaceutical supply chain
Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
You need to be a subscriber to read this article.
Click here
to find out more.
Industrial data mastery: navigating the 2025 landscape
As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
Novo Holdings completes acquisition of Catalent
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
ACG expands global footprint with new capsule manufacturing facility in Thailand
New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Ingredients
Averica expands pharmaceutical impurities services
Averica Discovery Services has expanded its service to include services such as nitrosamine and PFAS testing
Research & Development
Canadian-based Neopharm Labs completes acquisition of Boston-based Averica Discovery Services
The combined expertise creates a key player in the North American analytical market
Research & Development
Averica Discovery appoints Cynthia Berger as Vice President of Operations
Will contribute broadly to the firm's growth and development
Regulatory
Averica now able to handle Schedule I controlled substances
And expand the types of research that the company can support
Subscribe now